Fuchs' Endothelial Dystrophy
50
14
14
23
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.0%
3 terminated out of 50 trials
88.5%
+2.0% vs benchmark
12%
6 trials in Phase 3/4
22%
5 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (50)
A Comparison of Visual Functions and Side-effects After DSAEK or DMEK for Fuchs' Endothelial Dystrophy
Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
PVEK Corneal Implant For Treatment of Corneal Edema
Descemet Endothelial Thickness Comparison Trial II
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
The Belgian Endothelial Surgical Transplant of the Cornea
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
The OPTIMISE Study
Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty
DISCOVER Study: Microscope-integrated Intraoperative OCT Study
Brillouin Microscopy Used to Evaluate Corneal Mechanical Properties
FECD-TRACE: Fuchs' Endothelial Corneal Dystrophy TRAjectory and Correlation With Genotype in the United Kingdom
The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery
Endothelial Side Up Inverted Femtosecond Laser Assisted DSAEK
PIONEER: Intraoperative and Perioperative OCT Study
Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy
Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty
TTHX1114(NM141) in Combination With DWEK/DSO
Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty